CoChat

Methodological issues limit interpretation of negative effects of satellite cell depletion on adult muscle hypertrophy

Open access
McCarthy, John J., Dupont-Versteegden, Esther E., Fry, Christopher S., Murach, Kevin A., Peterson, Charlotte A. · 2017 · Development
Cited by 49

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

We are writing regarding the recent publication in Development entitled ‘Satellite cell depletion prevents fiber hypertrophy in skeletal muscle’ (Egner et al., 2016). Egner et al. claim to have ‘essentially repeated’ our work (McCarthy et al., 2011); however, we think that methodological differences between the two studies make it impossible to compare the results directly. More importantly, technical problems with their analyses and lack of controls make it impossible to attribute the lack of growth that they observed to the loss of satellite cells (SCs). We have not studied hypertrophy in the extensor digitorum longus (EDL) muscle, as the mechanics and function of the tibialis anterior (TA)/EDL do not support the relevance of a synergist ablation-mechanical overload model. The EDL is only activated during the ‘swing phase’ of walking, designed for velocity at the expense of force. It operates essentially unloaded, undergoing only concentric contractions to lift the weight of the foot during ambulation (Carlson-Kuhta et al., 1998), so removing the TA should have little effect on the size of EDL (Lieber and Ward, 2011). On the other hand, the gastrocnemius, soleus and plantaris muscles are designed for force production and, following removal of the gastrocnemius muscle, the plantaris experiences significant concentric and eccentric loading during walking, the latter being crucial for hypertrophy (Booth and Thomason, 1991; Gregor et al., 2006). Thus, we will limit our comments to the results reported from the plantaris following synergist ablation, a well-accepted hypertrophic model.We have performed synergist ablation surgery on hundreds of Pax7-DTA mice treated with tamoxifen to deplete SCs or vehicle, starting when they are at least 4 months old, and consistently find no difference in the plantaris growth response, as defined by muscle mass and fiber cross-sectional area (CSA), in the first 2 weeks. We do not include tamoxifen-treated mice that are less than 90% depleted in our analyses, and we do not observe significant proliferation of the few remaining SCs at 2 weeks, or myonuclear accretion into fibers. By contrast, Egner et al. report an average of only 76% depletion, and a 420% increase in SCs in their SC-depleted, overloaded (SC−OL+) plantaris; this level of depletion should have limited effect on growth. However, the fact that they detect only about five SCs in the entire cross-section of the control SC+OL− plantaris (figure 1B in Egner et al., 2016), makes the entire quantification questionable. That SCs are not effectively depleted is most clearly demonstrated by the observation that markers of muscle regeneration [embryonic myosin heavy chain (eMyHC)-positive and centrally nucleated fibers] are significantly higher in SC− compared with SC+ plantaris with overload (figure 2B-D in Egner et al., 2016). We reported that SC-depleted muscle showed significantly fewer eMyHC+ fibers compared with vehicle-treated OL+, as expected, and severely impaired regeneration capacity after BaCl2 injection. The higher regenerative response in plantaris from tamoxifen- compared with vehicle-treated mice in the Egner study suggests that there is actually more SC activity in response to overload in SC− mice, making the lack of growth even more inexplicable. Without the appropriate control – the parental Pax7-CreER strain tamoxifen treated (Fry et al., 2014; Jackson et al., 2015) and subjected to overload (Fry et al., 2014) – no conclusions regarding the specific effect of SC depletion, as opposed to tamoxifen toxicity, on growth can be drawn from the Egner study.We think a much more reasonable explanation for the lack of growth reported by Egner et al. is that their tamoxifen-treated mice were unhealthy, as evidenced by lower body weight. They report that tamoxifen-treated mice had a 13% lower body weight than vehicle-treated mice. The tamoxifen-treated mice in our 2011 study showed 4% lower body weight compared with vehicle-treated mice (vehicle, 24.5±2.7 g; tamoxifen, 23.5±2.5 g), which was not statistically different. This is also the case for tamoxifen- compared with vehicle-treated mice from our various studies in both male (Fry et al., 2014, 2015; McCarthy et al., 2011) and female (Jackson et al., 2015, 2012) mice. As stated above, the parental Pax7-CreER strain must be tamoxifen treated to rule out tamoxifen toxicity accounting for the lack of growth in the Egner study.In addition to being unhealthy, we posit that the difference in response to tamoxifen observed between the studies is due to the fact that the mice in the Egner study were less than 4 months old at the time of tamoxifen treatment, and thus were still growing. Femur and humerus growth increases rapidly from 4 to 12 weeks, after which time longitudinal bone growth appears to cease (Ferguson et al., 2003). We only use mice that are 4 months of age or older to be sure we are past the period of long bone growth, and therefore muscle growth, as we exp

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/dev.145797

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 49

Metadata

Authors
McCarthy, J. J., Dupont-Versteegden, E. E., Fry, C. S., Murach, K. A., & Peterson, C. A.
Venue
Development
Published
2017-04-15
Volume
144
Issue
8
Pages
1363-1365
ISSN
  • 0950-1991 (ISSN-L)
  • 1477-9129
OpenAlex
W2606739720
Cited by
49
References
4
FWCI
1.94
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.